Integrating oncogenetics testing into African clinics and cancer control programs

Toripalimab plus chemotherapy improves 3-year survival in resectable gastric/GEJ cancer

Adjuvant pembrolizumab fails to improve recurrence-free survival after curative therapy in hepatocellular carcinoma

Physical activity reduces fatigue and improves quality of life in colorectal cancer survivors

Zanidatamab improves PFS and OS in first-line HER2-positive metastatic gastric cancer

Is caring beyond cure possible in African cancer care?

African Oncogenetics Network: improving training and infrastructure in low-resource regions

Hammamet Declaration on Oncogenetics in Africa: African Oncogenetics Network

The aims of the African Oncogenetics Network

The human crisis in cancer: a Lancet Oncology Commission

Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes following transplantation

MS-553 shows promise in treating chronic lymphocytic leukaemia